D-1490-2019 Class III Terminated
FDA drug recall D-1490-2019 was initiated by Lupin Pharmaceuticals Inc. on Jul 11, 2019 and is designated Class III. Reason for recall: Labeling: Missing label; Product complaints reported missing bottle label. The recall status is terminated (terminated Sep 9, 2020). Affected quantity: 17,238 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 24, 2019
- Initiation Date
- Jul 11, 2019
- Termination Date
- Sep 9, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 17,238 bottles
Product description
Gatifloxacin Ophthalmic Solution 0.5%, For Use in the Eyes Only, Rx Only, Sterile, 2.5 mL Bottle, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, India, NDC 68180-435-01.
Reason for recall
Labeling: Missing label; Product complaints reported missing bottle label.
Distribution pattern
Nationwide in the U.S. and PR.
Code information
Lot #: H805157, Exp. 05/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1490-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026